Quote | Janux Therapeutics Inc. (NASDAQ:JANX)
Last: | $47.72 |
---|---|
Change Percent: | -0.87% |
Open: | $45.07 |
Close: | $47.72 |
High: | $47.805 |
Low: | $44.2 |
Volume: | 461,634 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Janux Therapeutics Inc. (NASDAQ:JANX)
The appointment of Eric Dobmeier and Natasha Hernday to the Board brings extensive operational and business development experience to support corporate and pipeline strategy Janux also announced the resignation of Jay Lichter, Ph.D., from the Board, and the appointment of current Board me...
2024-07-10 14:06:41 ET Summary Context Therapeutics Inc.'s acquisition of CT-95, targeting MSLN expressing solid tumors, brings another shot on goal for its pipeline of T cell engagers. CTIM-76 is another T cell engager in the pipeline; however, it is being developed to go after o...
Message Board Posts | Janux Therapeutics Inc. (NASDAQ:JANX)
Subject | By | Source | When |
---|---|---|---|
Didn't you mean to say that "things are | mmayr | investorshub | 04/23/2008 12:00:44 AM |
That's a bunch of BS. I wish | mmayr | investorshub | 04/22/2008 11:55:49 PM |
To All Janex Shareholders: | isisevan | investorshub | 09/23/2005 7:28:13 PM |
Looks to me like this "Vince" character has | mmayr | investorshub | 08/21/2002 11:58:14 AM |
Hello pontang | Wise Investment | investorshub | 08/01/2002 6:57:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Janux Therapeutics Inc. Company Name:
JANX Stock Symbol:
NASDAQ Market:
Janux Therapeutics Inc. Website:
The appointment of Eric Dobmeier and Natasha Hernday to the Board brings extensive operational and business development experience to support corporate and pipeline strategy Janux also announced the resignation of Jay Lichter, Ph.D., from the Board, and the appointment of current Board me...
2024-06-12 18:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...